Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy

Supporting Information

• Supporting information Fig S1 - Polar metabolite following chemotherapy treatment data set
• Supporting information Fig S2 - Validation of ODC and ARG2 antibodies
• Supporting information Fig S3 - Polar metabolites following DFMO treatment data set
• Supporting information Fig S4 - Expression of KEGG metabolic genes in METABRIC breast samples